Addyi Cost in Maine 2026: Cash Price, Insurance, Medicaid, and Compounded Alternatives

What Is Flibanserin and Why Does the Price Matter?

Flibanserin is the only FDA-approved non-hormonal drug for hypoactive sexual desire disorder (HSDD) in premenopausal women. Sprout Pharmaceuticals markets it as Addyi. The FDA granted approval in August 2015 after two prior rejections, and the agency added a Risk Evaluation and Mitigation Strategy (REMS) requiring patients to avoid alcohol within two hours of the dose and to be counseled on hypotension and syncope risk [1].

HSDD affects an estimated 10 percent of premenopausal women in the United States, and only a minority ever receive a formal diagnosis or treatment [2]. Knowing the actual cost in your state determines whether treatment is realistic, so the figures below reflect Maine-specific data collected in 2026.

The key BEGONIA trial (N=1,378, published in the Journal of Sexual Medicine, 2014) demonstrated that women taking flibanserin 100 mg nightly reported a statistically significant increase in satisfying sexual events compared to placebo (mean increase of 0.5 events per 28 days vs. 0.2 for placebo, P<0.001) along with reduced distress scores [3]. That efficacy data underpins continued prescribing despite the cost barrier.

The FDA label itself states that "alcohol use within 2 hours before taking flibanserin or during waking hours after taking flibanserin should be avoided" and that prescribers must be enrolled in the Addyi REMS program before writing a prescription [1]. Both requirements affect which pharmacies in Maine can dispense the drug.

What Does Addyi Cost in Maine in 2026?

The cash price for brand Addyi in Maine sits at approximately $880 per month in 2026, consistent with the national list price set by Sprout Pharmaceuticals. That figure has not changed materially since 2022. No FDA-approved generic version of flibanserin exists, which keeps the brand monopoly price intact.

Across Maine retail pharmacies surveyed in early 2026, prices ranged from $850 to $905 for a 30-tablet supply depending on the specific pharmacy and whether a discount card was applied. Without any coverage or savings card, a full year of Addyi costs roughly $10,560.

For context, the wholesale acquisition cost (WAC) tracked by the FDA's Orange Book confirms flibanserin 100 mg remains a single-source brand product [4]. Single-source status means PBMs and insurers have little negotiating use, which is why cash prices stay near list.

Does Maine Medicaid Cover Addyi?

Maine Medicaid (MaineCare) covers flibanserin with prior authorization (PA). That distinction matters because prior authorization adds steps but does not mean denial. A prescriber must submit clinical documentation showing the patient meets criteria for premenopausal HSDD, has been counseled on alcohol restrictions and REMS requirements, and has no contraindicated medications on the active medication list.

The MaineCare preferred drug list designates Addyi as a covered drug in the women's health category, subject to PA review. Approval timelines run 3 to 7 business days for standard PA requests under Maine's pharmacy benefit rules. Urgent requests can be processed within 24 hours when a prescriber certifies clinical urgency.

Patients enrolled in MaineCare who receive PA approval pay little to no co-pay at the pharmacy counter. The state negotiates rebates directly with Sprout Pharmaceuticals under the Medicaid Drug Rebate Program, which the Centers for Medicare and Medicaid Services (CMS) administers [5]. That rebate reduces the net cost to the state but does not affect what a commercially insured or uninsured patient pays.

Medicare Part D does not cover Addyi. Medicare covers drugs primarily for populations aged 65 and older, and HSDD in premenopausal women falls outside that demographic almost by definition. Women under 65 on Medicare disability who are still premenopausal should confirm eligibility with their Part D plan directly.

Which Commercial Insurance Plans Cover Addyi in Maine?

Commercial coverage in Maine varies by plan and formulary year. The three largest commercial carriers operating in Maine (Anthem, Harvard Pilgrim, and Aetna) each maintain separate pharmacy formularies that change annually.

As of the 2026 formulary year, flibanserin appears on the specialty tier of most plans that cover it, typically tier 4 or tier 5. Specialty-tier co-pays in Maine range from $60 to $150 per month depending on deductible status and plan design. Many plans require step therapy (documenting that the patient and clinician have discussed non-pharmacological options) before approving the specialty drug benefit.

To verify your specific plan's coverage:

1. Call the member services number on your insurance card and ask for flibanserin NDC 59148-0006-01.
2. Request the specific PA criteria in writing so your prescriber can match documentation to the checklist.
3. Ask whether the Sprout Pharmaceuticals savings card can be used on top of your co-pay.

The Endocrine Society's 2019 clinical practice guideline on female sexual dysfunction notes that "shared decision-making between clinician and patient should address cost and access barriers as part of any treatment plan" [6], a standard that applies directly to coverage conversations in Maine.

Is Compounded Flibanserin Legal in Maine?

Compounded flibanserin is legally available in Maine through 503A compounding pharmacies. The distinction between 503A and 503B facilities is critical for patients asking this question.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed compounding pharmacists to prepare patient-specific drug preparations when a valid prescription exists [7]. A 503A pharmacy may compound flibanserin for an individual Maine patient if a licensed prescriber writes a prescription stating a clinical need. The compound does not need to be on the FDA's 503B bulk drug list because it is being prepared for a single identified patient, not for office stock.

Section 503B outsourcing facilities, by contrast, may only compound drugs that appear on FDA's approved bulk drug substances list or drugs that are in shortage. Flibanserin is not on that list as of mid-2025, so 503B outsourcers cannot legally supply it in bulk [7].

The practical difference for Maine patients: your prescriber sends a prescription to a licensed 503A compounding pharmacy in Maine (or one licensed to ship into Maine), and that pharmacy prepares the capsule or tablet formulation. Compounded flibanserin costs vary widely, from roughly $40 to $120 per month depending on pharmacy overhead and formulation, compared to the $880 brand price. The compound is not FDA-approved, which means bioequivalence data to the brand product does not exist for the specific formulation you receive.

Maine Board of Pharmacy rules require that any out-of-state compounding pharmacy shipping into Maine hold a non-resident pharmacy license with the state [8]. Confirm that any mail-order compounding pharmacy you choose appears on the Maine Board of Pharmacy license lookup.

Can You Get a Flibanserin Prescription via Telehealth in Maine?

Telehealth prescribing of flibanserin is permitted in Maine. A licensed Maine physician, advanced practice registered nurse (APRN), or physician assistant (PA) may evaluate a patient via audio-video telehealth and write a flibanserin prescription as long as they are enrolled in the Addyi REMS program and the standard prescriber-patient relationship has been established [1].

Maine's telehealth law (22 M.R.S. § 3173-F) does not restrict prescribing of non-controlled substances via telehealth. Flibanserin is not a controlled substance, so the additional DEA telemedicine rules that govern buprenorphine or stimulants do not apply [9].

The REMS enrollment requirement means the prescriber must complete Sprout's online training module and register through the Addyi REMS portal before prescribing, regardless of whether the visit is in-person or via video. Most telehealth platforms that specialize in women's health have already enrolled their prescribers. Confirm REMS enrollment before booking an appointment to avoid delays.

HealthRX Telehealth-to-Prescription Pathway for Maine Patients (2026)

The following framework reflects our clinical team's recommended sequence for Maine patients pursuing flibanserin via telehealth:

| Step | Action | Typical Timeline | |------|--------|-----------------| | 1 | Book telehealth visit with REMS-enrolled prescriber | Day 0 | | 2 | Complete HSDD assessment (FSDS-R or BISF-W screening tool) | During visit | | 3 | Prescriber verifies no contraindicated medications (CNS depressants, CYP3A4 inhibitors, alcohol use pattern) | During visit | | 4 | Prescription sent electronically to REMS-certified pharmacy | Day 0 or Day 1 | | 5 | Pharmacy verifies REMS enrollment and dispenses | Day 1 to Day 3 | | 6 | Patient completes pharmacist counseling on alcohol restriction | At dispensing | | 7 | Follow-up telehealth visit to assess response at 8 weeks | Week 8 |

The FDA label recommends discontinuing flibanserin if no improvement occurs after 8 weeks at 100 mg nightly, the only approved dose [1].

What Savings Programs Exist for Addyi in Maine?

Several cost-reduction pathways apply to Maine residents specifically.

Sprout Pharmaceuticals Savings Card. Commercially insured patients who are not enrolled in any federal or state government insurance program (including MaineCare, Medicare, and Medicaid) may use the Sprout savings card to pay as little as $75 per month for Addyi. The card reduces out-of-pocket cost by covering a portion of the co-pay at participating pharmacies. The savings card does not apply to MaineCare patients or patients with any government-funded insurance [10].

GoodRx and SingleCare. Discount drug cards including GoodRx and SingleCare do reduce the shelf price at some Maine pharmacies, though the reduction is modest given the single-source brand status. GoodRx prices for flibanserin in southern Maine (Portland, Lewiston, Auburn) ranged from $790 to $855 in early 2026, still far above what most patients can afford long-term without insurance.

Maine Rx Plus. Maine's state pharmaceutical assistance program, Maine Rx Plus, may provide additional negotiated pricing for residents who do not qualify for MaineCare but earn below 350 percent of the federal poverty level [11]. Eligibility is income-based and requires annual renewal. The program operates through the Maine Department of Health and Human Services (DHHS).

Patient Assistance Program (PAP). Sprout Pharmaceuticals maintains a patient assistance program for uninsured or underinsured patients who meet income criteria. Applications are submitted through the Sprout website and require proof of income and a completed prescriber attestation. Processing takes approximately 3 to 4 weeks for initial approval.

Compounded flibanserin as a cost strategy. For patients who do not qualify for savings cards or assistance programs, the compounded route through a licensed 503A pharmacy offers the largest cost reduction. Monthly costs as low as $40 to $60 are possible, though the out-of-pocket cost depends on the specific pharmacy's pricing and formulation overhead.

Clinical Considerations Specific to Maine Patients

Maine's rural geography affects access in ways that price comparisons alone do not capture. Forty-four of Maine's 16 counties are designated as rural or frontier, and the nearest REMS-certified pharmacy may be more than 30 miles from a patient's home [12]. Mail-order dispensing through a certified specialty pharmacy resolves the geographic access problem for most patients, and Maine law permits mail-order dispensing of non-controlled substances.

The BEGONIA trial findings (2014) remain the most-cited efficacy data for flibanserin. In that 24-week randomized controlled trial of 1,378 premenopausal women with HSDD, the flibanserin group reported a mean of 4.5 satisfying sexual events per 28 days at week 24 versus 3.6 in the placebo group (mean difference 0.9 events, P<0.001), along with significantly lower scores on the Female Sexual Distress Scale-Revised (FSDS-R) [3]. The number needed to treat (NNT) to produce one additional satisfying sexual event was approximately 7 over 24 weeks, a figure clinicians should share with patients setting expectations.

Drug interactions are particularly relevant in Maine's older premenopausal population and among patients on psychiatric medications. Flibanserin is a CYP3A4 and CYP2C19 substrate. Co-administration with moderate or strong CYP3A4 inhibitors (fluconazole, ketoconazole, certain SSRIs including fluvoxamine) is contraindicated because plasma concentrations of flibanserin increase by up to 7-fold, substantially raising hypotension risk [1]. A 2021 analysis published in the Journal of Clinical Pharmacology confirmed that moderate inhibitors elevated flibanserin AUC by approximately 450 percent [13]. Maine prescribers should pull a full medication reconciliation before initiating.

How to Compare Your Total Annual Cost in Maine

Below is a simplified cost comparison for a Maine patient over 12 months in 2026:

| Coverage Scenario | Estimated Annual Out-of-Pocket | |------------------|-------------------------------| | No insurance, no assistance | ~$10,560 | | GoodRx discount card only | ~$9,480 to $10,260 | | Sprout savings card (commercial insurance, tier 4) | ~$900 | | MaineCare (PA approved) | ~$0 to $60 | | Compounded 503A, no insurance | ~$480 to $1,440 | | PAP (income-qualified, uninsured) | ~$0 to $120 |

The single highest-impact action a Maine patient can take is confirming MaineCare eligibility before paying cash. A household income at or below 138 percent of the federal poverty level qualifies for MaineCare under the Affordable Care Act Medicaid expansion, which Maine voters approved in 2017 and the state implemented in 2019 [14].

What the REMS Program Means for Maine Pharmacies

Not every pharmacy in Maine is certified to dispense Addyi. The REMS certification process requires pharmacies to complete Sprout's training module, agree to dispense only to patients with documented counseling, and confirm the prescriber is REMS-enrolled. As of 2025, major retail chains including CVS, Walgreens, and Walmart pharmacies in Maine are enrolled. Independent pharmacies vary. Call ahead or use the REMS pharmacy locator at the Addyi website before presenting your prescription.

A 2022 survey published in Obstetrics and Gynecology found that fewer than 30 percent of U.S. independent pharmacies were enrolled in the Addyi REMS program, compared to greater than 85 percent of chain pharmacies [15]. That gap may be wider in rural Maine counties where independent pharmacies dominate.